HIV-1 disease progression during highly active antiretroviral therapy: an application using population-level data in British Columbia: 1996-2011.
about
Fifteen-Year Trends in the Prevalence of Diabetes among Hospitalized HIV-Infected Patients in Spain (1997-2012)The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.The causal effect of opioid substitution treatment on HAART medication refill adherenceCost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.Probability of a false-negative HIV antibody test result during the window period: a tool for pre- and post-test counselling.The Association of HIV-Related Stigma to HIV Medication Adherence: A Systematic Review and Synthesis of the Literature.Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study.Estimating State Transitions for Opioid Use Disorders.Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.A state transition framework for patient-level modeling of engagement and retention in HIV care using longitudinal cohort data.The cost-effectiveness of HIV testing and treatment engagement initiatives in British Columbia, Canada: 2011-2013.
P2860
Q28553878-D6B3768A-0E1B-41F6-A473-F520CCFAD2CCQ33598342-818DEA0B-D37E-4B4D-AE47-FCDC8F081F6BQ33803319-EDDCEC36-A422-4749-9A93-1BF818182150Q35119311-7E2C2375-897B-4D5D-9C0A-DBDCFD6056A7Q36093606-2249E6EF-F830-4EA6-AAB3-3C4BFBFD6EF5Q36175183-1CAC01B6-5150-4230-BA89-67F96951D39AQ36205807-96F3FC7C-5258-45C0-9962-17E43A8DE99CQ38230641-69824FD7-796F-4573-8940-64E5D8F8F781Q38572844-33948D8B-B0D0-43A0-B4FC-84C63A96FF43Q38861807-ABCA6C14-ADF4-4101-932A-B0D2FA3228AAQ39062397-60F3A056-93EA-4DDA-BBE4-78B0E3C313E1Q45326055-C18FFD17-FB7B-4396-AB11-4A487D1B88C9Q46329396-769466C8-C87A-4114-B960-1B3160EFBD22Q47801305-25D08269-10BA-4EA1-AF57-2FE3004C78E8
P2860
HIV-1 disease progression during highly active antiretroviral therapy: an application using population-level data in British Columbia: 1996-2011.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HIV-1 disease progression duri ...... n British Columbia: 1996-2011.
@ast
HIV-1 disease progression duri ...... n British Columbia: 1996-2011.
@en
type
label
HIV-1 disease progression duri ...... n British Columbia: 1996-2011.
@ast
HIV-1 disease progression duri ...... n British Columbia: 1996-2011.
@en
prefLabel
HIV-1 disease progression duri ...... n British Columbia: 1996-2011.
@ast
HIV-1 disease progression duri ...... n British Columbia: 1996-2011.
@en
P2093
P2860
P1476
HIV-1 disease progression duri ...... n British Columbia: 1996-2011.
@en
P2093
Benita Yip
Bohdan Nosyk
STOP HIV/AIDS Study Group
Viviane D Lima
P2860
P304
P356
10.1097/QAI.0B013E3182976891
P407
P577
2013-08-01T00:00:00Z